참고문헌
- Lee, J. I.; Park, H.; Yun, Y. S.; Kwon, S. K. J. Kor. Chem. Soc. 2001, 45, 386
- Kwon, S. K.; Kim, M. K. Yakhak Hoeji 2002, 46, 89
- Kwon, S. K. Yakhak Hoeji 2002, 46, 155
- Kwon, S. K.; Moon, A. R. Arch. Pharm. Res. 2005, 4, 391
- Jung, M. Y.; Kwon, S. K.; Moon, A. Eur. J. Cancer 2001, 37, 2104 https://doi.org/10.1016/S0959-8049(01)00242-8
- Tisler, M.; Stanovnik, B. Advances in Heterocyclic Chemistry; Katritzky & Boulton, Eds.; 1984; Vol. 3, pp 1-56
- Song, J. H.; Kim, S. G.; No, Z. S.; Hyun, Y. L.; Jeon, D. J.; Kim, I. Bull. Korean Chem. Soc. 2008, 29, 1467 https://doi.org/10.5012/bkcs.2008.29.8.1467
- Contreras, J. M.; Parrot, I.; Sippl, W.; Rival, Y. M.; Wermuth, C. G. J. Med. Chem. 2001, 44, 2707 https://doi.org/10.1021/jm001088u
- Parrot, I.; Wermuth, C. G.; Hibert, M. Tetrahedron Lett. 1999, 40, 7975 https://doi.org/10.1016/S0040-4039(99)01533-6
- Wermuth, C. G.; Bourguignon, J.; Schlewer, G.; Gies, J.; Schoenfelder, A.; Melikian, A.; Bouchet, M. J. Med. Chem. 1987, 30, 239 https://doi.org/10.1021/jm00385a003
- Shin, H. S.; Kwon, S. K. Arch. Pharm. Res. 2003, 5, 351
- Wermuth, C. G.; Schlewer, G.; Bourguignon, J. J.; Maghiros, G.; Bouchet, M. J.; Moire, C.; Kan, J. P.; Worms, P.; Biziere, K. J. Med. Chem. 1989, 32, 528 https://doi.org/10.1021/jm00123a004
- Kleemann, A.; Engel, J. Pharmaceutical Substances, 4th ed.; 2001; pp 1340-1342
- Contreras, J. M.; Rival, Y. M.; Chayer, S.; Bourguignon, J. J.; Wermuth, C. G. J. Med. Chem. 1999, 42, 730 https://doi.org/10.1021/jm981101z
- Park, E. H.; Park, M. S. Yakhak Hoeji 2005, 49(1), 56
- Park, E. H.; Park, M. S. J. Kor. Chem. Soc. 2007, 51(3), 244 https://doi.org/10.5012/jkcs.2007.51.3.244
- Kwon, S. K.; Lee, M. S. Yakhak Hoeji 2005, 49(6), 505
- Parrot, I.; Rival, Y.; Wermuth, C. G. Synthesis 1999, 7, 1163
- Lu, Z.; Twieg, R. J. Tetrahedron 2005, 61, 903 https://doi.org/10.1016/j.tet.2004.11.017
- Eldrup, A. B.; Dahl, O.; Nielsen, P. J. Am. Chem. Soc. 1997, 119, 1116 https://doi.org/10.1021/ja962058c
- Beletskaya, I.; Bessmertnykh, G.; Guilard, R. Tetrahedron Lett. 1999, 40, 6393 https://doi.org/10.1016/S0040-4039(99)01246-0
- Tewari, A.; Hein, M.; Zapt, A.; Beller, M. Tetrahedron 2005, 61, 9705 https://doi.org/10.1016/j.tet.2005.06.067
- Yokoyama, R.; Ito, S.; Okujima, T.; Kubo, T.; Yasunami, M.; Tajiri, A.; Morita, N. Tetrahedron 2003, 59, 8191 https://doi.org/10.1016/j.tet.2003.08.048
피인용 문헌
- Incorporation of pyridazine rings in the structure of functionalized π-conjugated materials vol.1, pp.3, 2011, https://doi.org/10.1039/c1ra00207d
- Novel Alkylaminopyridazine Derivatives: Synthesis and Their Anti-proliferative Effects against MCF-7 Cells vol.34, pp.11, 2013, https://doi.org/10.5012/bkcs.2013.34.11.3317
- Design, Synthesis, and Biological Evaluation of Selenium-incorporated Aminopyridazines as Anticancer Agents vol.36, pp.6, 2015, https://doi.org/10.1002/bkcs.10319
- Synthesis and Antiproliferative Activities of Chloropyridazine Derivatives Retain Alkylsulfonyl Moiety vol.37, pp.11, 2016, https://doi.org/10.1002/bkcs.10967
- ChemInform Abstract: Synthesis of Novel Allylthio Heterocyclo(or aryl)alkylaminopyridazines and Their Anticancer Activity Against SK-Hep-1 Cells. vol.40, pp.28, 2009, https://doi.org/10.1002/chin.200928141
- Synthesis and anticancer activities of new 3-allylthio-6-(mono or disubstituted)aminopyridazines vol.33, pp.2, 2010, https://doi.org/10.1007/s12272-010-0201-x
- Synthesis and Antitumor Activity of New 3-Allylseleno-6-alkoxypyridazines against Breast Cancer MCF-7 Cells vol.35, pp.5, 2009, https://doi.org/10.5012/bkcs.2014.35.5.1533
- RKO 대장암세포에서 3-헵틸아미노-6-알릴티오피리다진과 3-디펜틸아미노-6-알릴티오피리다진의 항암기전 vol.60, pp.3, 2009, https://doi.org/10.17480/psk.2016.60.3.101
- Base Promoted Three-Component Annulation of 4-Diazoisochroman-3-imines with Dimethylsulfonium Ylides: Synthesis of Highly Functionalized Isochromeno[4,3-c]pyridazines vol.86, pp.1, 2021, https://doi.org/10.1021/acs.joc.0c02204